SCHEMBL374532

SCHEMBL374532

CCCCCCCOS(=O)(=O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 10/20 0.61
▸ CA2 P00918 10/20 0.61
▸ CA9 Q16790 8/20 0.61
▸ CA12 O43570 3/20 0.61
▸ CA7 P43166 3/20 0.61
▸ CA14 Q9ULX7 3/20 0.61
▸ CA3 P07451 2/20 0.61
▸ CA4 P22748 2/20 0.61
▸ CA6 P23280 2/20 0.61
▸ CA5A P35218 2/20 0.61
▸ CA5B Q9Y2D0 2/20 0.61
▸ RECQL P46063 2/20 0.59
▸ GLA P06280 1/20 0.59
▸ HPGD P15428 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ EPHX2 P34913 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ CES2 O00748 1/20 0.48
▸ FNTA P49354 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185577 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL186596 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL148281 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL147680 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL1655279 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL11064484 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL10715880 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL143597 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL22283885 1.00 CA1 (0.61) CA1CA2CA9CA12CA7
SCHEMBL770634 1.00 CA1 (0.61) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183220-B1 BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY UNIV DUBLIN CITY (IE) 2016-11-09 — — EP claimed
WO-2015191686-A1 METHODS OF ADMINISTERING METHYLNALTREXONE SALIX PHARMACEUTICALS, INC. (US) 2015-12-17 — — WO claimed
US-8864883-B2 Surface treatments for dessicant media in a water recovery device Z124 (KY) 2014-10-21 — — US claimed
US-20130319022-A1 SURFACE TREATMENTS FOR DESSICANT MEDIA IN A WATER RECOVERY DEVICE Z124 (KY) 2013-12-05 — — US claimed
US-8541598-B2 Biodegradable solvents for the chemical industry DUBLIN CITY UNIVERSITY (IE) 2013-09-24 — — US claimed
US-20110247494-A1 LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS VTU Holding GmbH. (AT) 2011-10-13 — — US claimed
US-20110201824-A1 BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY DUBLIN CITY UNIVERSITY (IE) 2011-08-18 — — US claimed
EP-2183220-A1 BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY Dublin City University (IE) 2010-05-12 — — EP claimed
US-7501522-B2 Method for the production of purified 1,3-substituted imidazolium salts BASF AKTIENGESELLSCHAFT (DE) 2009-03-10 — — US claimed
WO-2009024607-A1 BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY DUBLIN CITY UNIVERSITY (IE) 2009-02-26 — — WO claimed
US-6878411-B2 Bath for the electrochemical deposition of high-gloss white rhodium coatings and whitening agent for the same UMICORE GALVANOTECHNIK GMBH (DE) 2005-04-12 — — US claimed
WO-2005019183-A1 METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS BASF AKTIENGESELLSCHAFT (DE) 2005-03-03 — — WO claimed
CN-1181226-C Electrolytic deposition bath for high gloss white rhodium coatings OMG��Ƽ������޹�˾ 2004-12-22 — — CN claimed
US-6814850-B1 EXTENDING CURRENT DENSITY WORKING RANGE; MINIMIZING PH EFFECT; INCREASING CURRENT EFFICIENCY AND DEPOSITION PERFORMANCE; INCLUDING SULFONATE OR SULFATE COMPONENT UMICORE GALVANOTECHNIK GMBH (DE) 2004-11-09 — — US claimed
US-20030111352-A1 Bath for the electrochemically depositing highly lustrous white rhodium coatings and whitening agent for the same UMICORE GALVANOTECHNIK GMBH (DE) 2003-06-19 — — US claimed
CN-1420948-A Bath for electrochemically depositing highly lustrous white rhodium coatings and whitening agent for same OMG ELECTROPLATING TECHNOLOGIE (DE) 2003-05-28 — — CN claimed
EP-1244827-A1 BATH FOR ELECTROCHEMICALLY DEPOSITING HIGHLY LUSTROUS WHITE RHODIUM COATINGS AND WHITENING AGENT FOR THE SAME Degussa Galvanotechnik GmbH (DE) 2002-10-02 — — EP claimed
WO-2001048273-A1 BATH FOR ELECTROCHEMICALLY DEPOSITING HIGHLY LUSTROUS WHITE RHODIUM COATINGS AND WHITENING AGENT FOR THE SAME DEGUSSA GALVANOTECHNIK GMBH (DE) 2001-07-05 — — WO claimed
US-4910031-A Topped savory snack foods FRITO-LAY, INC. (US) 1990-03-20 — — US claimed
EP-0207516-A1 An ingestible product containing a sweetness inhibitor and process for inhibiting sweetness in an ingestible product GENERAL FOODS CORPORATION (US) 1987-01-07 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201824-A1 BIODEGRADABLE SOLVENTS FOR THE CHEMICAL INDUSTRY TIMM9, B2M, TIMM44 CA1 4016/4885CA2 2237/4885CA9 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback